الابحاث

South Egypt Cancer Institute

Assiut University

Department of Medical Oncology
# Title Research Member Research Year
11 Predictive Factors for Site of Local and Systemic Recurrence in Breast Cancer Patients Dr. Salah Mabrouk Khallaf Abd Rabou 2025
12 Non-Metastatic Triple Negative Breast Cancer with Neuroendocrine Differentiation: Survival Parameters Dr. Ahmed Mubarak Hefni Ismail 2025
13 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Amany Mohammed Abdel Moatamed 2024
14 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Dr. Hanaan Ahmed Mohammed Ahmed 2024
15 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Dr. Salah Mabrouk Khallaf Abd Rabou 2024
16 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Dr. Shimaa Hassan Shabaan Hassan 2024
17 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Dr. Adel Gomaa Mohamed Gabr 2024
18 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Dr. Amen Hamdy Zaki Ali 2024
19 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Hadeer Mohamed Saad Elshazly 2024
20 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Prof. Ashraf Zeidan Abdalla Ahmed 2024